HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

histone DNA binding protein-1

sequence-specific DNA-binding protein that interacts with the hexameric sequence ACGTCA; from wheat; see also records for HBP-1a & HBP-1b

Also Known As:

HBP-1

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - DNA-Binding Proteins: 2009
    - histone DNA binding protein-1: 4

Experts

1.	Chen, Heming: 1 article (01/2017)
2.	Gu, Lu: 1 article (01/2017)
3.	Li, Xiaoyi: 1 article (01/2017)
4.	Liu, Shuiyi: 1 article (01/2017)
5.	Zhou, Xinmin: 1 article (01/2017)
6.	Altmann, Annette: 1 article (03/2009)
7.	Eisenhut, Michael: 1 article (03/2009)
8.	Garcia-Boy, Regine: 1 article (03/2009)
9.	Haberkorn, Uwe: 1 article (03/2009)
10.	Herold-Mende, Christel: 1 article (03/2009)

Related Diseases

1.	Urinary Bladder Neoplasms (Bladder Cancer) 10/15/1989 - "By contrast, urine from bladder cancer patients reacted positively with the RBS-31 MAb at 72%, with the RBS-85 MAb at 63%, with the RBA-1 MAb at 51% and with the HBP-1 MAb at 35%. " 10/15/1989 - "RBS-31 and RBS-85 mouse MAbs and RBA-1 rat MAb were raised against BC47 cells and HBP-1 MAb was raised against human bladder cancer tissues. " 06/01/1987 - "Four other antibodies termed S31, S85, HBP-1 and RBM-1 reacted with antigens in urine from patients with bladder tumor and other types of uropathy, in contrast to their low reactivities against urine from healthy donors."
2.	Atherosclerosis 01/01/2017 - "MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis."
3.	Neoplasms (Cancer) 03/01/2009 - "The results were further validated in human HNSCC tumor tissue sections using fluorescence-labeled HBP-1. " 03/01/2009 - "Peptide immunohistochemistry of HNSCC tissue sections exhibited tumor staining by HBP-1, whereas normal tissue remained negative. "
4.	Inflammation (Inflammations) 01/01/2017 - "MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis."
5.	Squamous Cell Carcinoma of Head and Neck 03/01/2009 - "HBP-1 represents a promising lead structure for the development of targeted therapies or diagnostic procedures in patients with HNSCC." 03/01/2009 - "The results were further validated in human HNSCC tumor tissue sections using fluorescence-labeled HBP-1. " 03/01/2009 - "Peptide immunohistochemistry of HNSCC tissue sections exhibited tumor staining by HBP-1, whereas normal tissue remained negative. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Antigens
3.	Antibodies

Related Therapies and Procedures

1.	Therapeutics